Related Experiment Video
Updated: Jul 16, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Serum and urine interleukin-6 and transforming growth factor-beta1 in young infants with pyelonephritis
Emmanouil Galanakis1, Maria Bitsori, Helen Dimitriou
1Department of Pediatrics, University Hospital of Heraklion, Heraklion, Greece.
Insights
Interleukin-6 (IL-6) is implicated in early pyelonephritis in infants, as indicated by elevated urine IL-6 levels. Transforming growth factor-beta1 (TGF-beta1) does not appear to play a significant role in the acute phase of this infection.
Area of Science:
- Pediatric Nephrology
- Infectious Diseases
- Immunology
Background:
- Cytokines are crucial in the acute response to pyelonephritis and subsequent renal scarring.
- Assessing pro-inflammatory (IL-6) and anti-inflammatory/pro-fibrotic (TGF-beta1) cytokines is important in young infants with pyelonephritis.
Purpose of the Study:
- To evaluate serum and urine concentrations of IL-6 and TGF-beta1 in infants with pyelonephritis.
- To understand the role of these cytokines in the early pathogenesis of pyelonephritis in neonates and young infants.
Main Methods:
- Serum and urine samples collected from infants with pyelonephritis and non-renal fever.
- Enzyme immunoassay used to quantify IL-6 and TGF-beta1 concentrations.
- Comparison of cytokine levels between pyelonephritis patients and control groups.
Main Results:
- No significant difference in serum IL-6 or TGF-beta1 between pyelonephritis infants and controls.
- Significantly higher urine IL-6 levels observed in infants with pyelonephritis compared to controls (P=0.0106).
- Urine TGF-beta1 levels were lower in pyelonephritis infants, but this difference was not statistically significant (P=0.0705).
Conclusions:
- IL-6 is confirmed to be involved in the early stages of pyelonephritis pathogenesis in young infants.
- TGF-beta1 does not appear to be significantly involved in the acute phase of pyelonephritis.
- Further research is needed to clarify the role of TGF-beta1 in the development of renal scarring associated with pyelonephritis.
Background:
Cytokines are involved both in the acute response during pyelonephritis and in the progression to renal scarring. The aim of the present study was to assess the pro-inflammatory interleukin-6 (IL-6) and the anti-inflammatory pro-fibrotic transforming growth factor-beta1 (TGF-beta) in very young infants with pyelonephritis.
Methods:
Serum and urine concentrations of IL-6 and TGF-beta1 were determined by enzyme immunoassay in infants with acute pyelonephritis before antibiotic treatment and in infants with non-renal fever. IL-6 was studied in 12 infants with pyelonephritis and in eight with non-renal fever (median ages, 2 months for both groups). TGF-beta1 was studied in 11 infants with pyelonephritis and in nine with non-renal fever (median ages, 2 and 4 months, respectively).
Results:
No significant differences were documented in serum concentrations of IL-6 and TGF-beta1 between patients and controls. Urine IL-6 levels were significantly higher in infants with pyelonephritis than in controls (medians, 147 and 21.4 pg/ml, respectively; P = 0.0106). The urine levels of TGF-beta1 were lower in infants with pyelonephritis than in controls, although not significantly (medians, 6.12 and 11.0 ng/ml, respectively; P = 0.0705).
Conclusions:
Our findings confirm the implication of IL-6 but not of TGF-beta1 in the pathogenesis of the early stages of pyelonephritis in young infants. Tauhe role of the pro-fibrotic TGF-beta1 in the development of renal scarring deserves further investigation.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pyelonephritis I: Introduction
Serum Studies: Renal Function Tests